Moxifloxacin Plus Metronidazole Versus Piperacillin/Tazobactam for the Treatment of Patients With Intra-abdominal Abscesses (MEMO)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2010 by Hannover Medical School.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Bayer
Information provided by:
Hannover Medical School
ClinicalTrials.gov Identifier:
NCT00629135
First received: February 25, 2008
Last updated: June 21, 2011
Last verified: May 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2012
  Estimated Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)